CLDX: Volume dana dhuwit perusahaan Celldex Therapeutics Inc

Tandha merek celldex.com (CLDX)

The clinical potential of new allergy-fighting antibodies serves as the primary growth catalyst for Celldex Therapeutics (CLDX), as evidenced by the company's free cash flow, where the current parameter equals 0.64. However, the business relies on external manufacturers, remaining dependent on their logistics. Risks are tied to testing uncertainty and competition. Liquidity dynamics help assess the balance between financial stability and capital efficiency.

CLDX - Cadangan dhuwit perusahaan Celldex Corp ing rentang 04.07.2022 - 21.11.2026

Rincian metrik keuangan lan pasar Celldex (CLDX)

- nilai saham lan prakiraan konsensus rega:
Ringkesan analisis perusahaan:Celldex Therapeutics
Sampel barang Celldex Therapeutics Inc

This indicator measures the volume of real liquid reserves to assess the business's ability to meet its obligations in the absence of revenue, serving as a fundamental stress-testing tool for financial stability. For the non-cyclical biopharma business of Celldex Therapeutics (CLDX), where development depends on clinical trials, the cash position confirms the autonomy of scientific assets from macroeconomics, determining the company's fundamental margin of safety.

Pesaing langsung

Volume dana dhuwit perusahaan ARGX|BioNTech - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan ABVX (abivax.com)|Sisa dhuwit perusahaan ADMA|Protagonist Therapeutics, Inc. - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Immunovant, Inc.|KNSA: Volume dana dhuwit perusahaan|GRFS - Aset likuid perusahaan|ADPT (Adaptive Biotechnologies Inc.) - Volume dana dhuwit perusahaan|AUPH: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan BCRX|VERA (Vera Pharma) - Sisa dhuwit perusahaan|Dianthus Pharma - Dhuwit awis perusahaan|Sisa dhuwit perusahaan PHVS|AbCellera Biologics - Volume dana dhuwit perusahaan|Sisa dhuwit perusahaan TRML (Tourmaline Bio)|PGEN: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Pharming Group N.V. (PHAR)|Dana dhuwit perusahaan Nektar|upstreambio.com (UPB) - Aset likuid perusahaan|Dana dhuwit perusahaan Zenas Bio (ZBIO)|Aset likuid perusahaan Immunome Inc|Dana dhuwit perusahaan Gossamer Bio, Inc. GOSS|Volume dana dhuwit perusahaan KalVista Pharmaceuticals Inc KALV|SEPN - Dana dhuwit perusahaan|PVLA - Volume dana dhuwit perusahaan|SVRA: Volume dana dhuwit perusahaan|RIGL - Aset likuid perusahaan|ANAB (AnaptysBio Inc) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Astria Corp (ATXS)|Volume dana dhuwit perusahaan ENGN|Aset likuid perusahaan rapt.com|Volume dana dhuwit perusahaan JBIO (Aerovate Therapeutics Inc)|Aset likuid perusahaan Aclaris Therapeutics, Inc. (ACRS)|KYTX - Dana dhuwit perusahaan|Aset likuid perusahaan Tiziana Life Sciences TLSA|CABA: Volume dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan VTYX|Dhuwit awis perusahaan THTX|Volume dana dhuwit perusahaan Avalo Therapeutics Inc.|Dana dhuwit perusahaan Eledon (ELDN)|Volume dana dhuwit perusahaan Agenus Inc (AGEN)|Volume dana dhuwit perusahaan CLYM (climbbio.com)|ZURA - Dhuwit awis perusahaan|atyrpharma.com - Volume dana dhuwit perusahaan|ADAG (adagene.com) - Dhuwit awis lan setara dhuwit awis perusahaan|IMA (Ikena Oncology) - Dhuwit awis perusahaan|Dhuwit awis perusahaan Shattuck Labs Inc|EQ (Equillium Inc) - Volume dana dhuwit perusahaan|CNTB: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan IMUX|ATRA (Atara Biotherapeutics, Inc.) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan IFRX (inflarx.de)|X4 Pharmaceuticals - Dana dhuwit perusahaan|Adicet Bio, Inc. - Volume dana dhuwit perusahaan|CELU (celularity.com) - Dhuwit awis lan setara dhuwit awis perusahaan|INMB: Volume dana dhuwit perusahaan|Barinthus Biotherapeutics PLC (BRNS) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Kezar Life Sciences|Dhuwit awis perusahaan SAB Biotherapeutics (SABS)|Dana dhuwit perusahaan Akari Therapeutics Plc (AKTX)|Dhuwit awis perusahaan Enlivex Therapeutics, Ltd. ENLV|Q32 Bio Inc. - Dhuwit awis perusahaan|GeoVax Labs (GOVX) - Cadangan dhuwit perusahaan|edesabiotech.com - Volume dana dhuwit perusahaan|Aset likuid perusahaan iBio Corp IBIO|CARM: Volume dana dhuwit perusahaan|xtlbio.com (XTLB) - Volume dana dhuwit perusahaan|BOLT (Bolt Biotherapeutics) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan HCW Biologics (HCWB)|Dhuwit awis perusahaan APVO (Aptevo Therapeutics)|AIM - Cadangan dhuwit perusahaan|Aditxt - Dhuwit awis perusahaan|Posisi dhuwit perusahaan gribio.com|XRTX: Dhuwit awis perusahaan|Sisa dhuwit perusahaan HIND (Vyome Holdings)|REVB (Revelation Bio) - Dhuwit awis perusahaan|Indaptus Corp (INDP) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan scinai.com|Dhuwit awis perusahaan CalciMedica, Inc. (CALI)|Dana dhuwit perusahaan Affimed NV (AFMD)|Dana dhuwit perusahaan ALLK (Allakos Inc)|Dana dhuwit perusahaan HOOKIPA Pharma, Inc. HOOK|Aset likuid perusahaan IGM Bio (IGMS)|iTeos Pharma - Volume dana dhuwit perusahaan|Aset likuid perusahaan oceanbiomedical.com OCEA|TC BioPharm (TCBP) - Dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan THRD